Tomoka Usami

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial

Domenica Lorusso, Yang Xiang, Kosei Hasegawa et al. · The Lancet · 2024 · 296 citations

Advanced Cervical Cancer, Cervical Cancer, Cervical Health +9

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

Domenica Lorusso, Yang Xiang, Kosei Hasegawa et al. · The Lancet · 2024 · 130 citations

Advanced Cervical Cancer, Cervical Cancer Management, Cervical Cancer +10

Comparison of pregnancy outcomes between women with early‐onset and late‐onset gestational diabetes in a retrospective multi‐institutional study in Japan

Tomoka Usami, Maki Yokoyama, Megumi Ueno et al. · Journal of Diabetes Investigation · 2019 · 42 citations · Full text

Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from <scp>KEYNOTE</scp>‐826

Shin Nishio, Kan Yonemori, Tomoka Usami et al. · Cancer Science · 2022 · 33 citations · Full text

Review of Treatment and Prognosis of Stage IVB Cervical Carcinoma

Tomoka Usami, Akimasa Takahashi, Maki Matoda et al. · International Journal of Gynecological Cancer · 2016 · 22 citations